DAVID POPLACK to Cyclophosphamide
This is a "connection" page, showing publications DAVID POPLACK has written about Cyclophosphamide.
Connection Strength
0.589
-
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 01; 23(7):1555-63.
Score: 0.206
-
New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23.
Score: 0.129
-
Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys. Cancer Res. 1988 Apr 15; 48(8):2113-5.
Score: 0.064
-
Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Cancer Res. 1987 Nov 15; 47(22):5932-4.
Score: 0.062
-
Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62.
Score: 0.037
-
Bacillus Calmette-Gu?rin enhancement of colony-stimulating activity and myeloid colony formation following administration of cyclophosphamide. Cancer Res. 1979 Jul; 39(7 Pt 1):2544-6.
Score: 0.035
-
Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127.
Score: 0.020
-
Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4.
Score: 0.013
-
Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Gu?rin. Cancer Res. 1978 Apr; 38(4):1049-51.
Score: 0.008
-
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep. 1978 Feb; 62(2):247-50.
Score: 0.008
-
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr; 68(4):486-91.
Score: 0.002
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.002
-
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63.
Score: 0.002
-
Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography. J Pediatr. 1977 Jul; 91(1):77-9.
Score: 0.002